Triple-negative breast cancer (TNBC) is a subtype, which lacks estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor-2 (HER-2) expression. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.